The Oracle Speaks

The Oracle Speaks

July 22nd, 2012
Introducing
The Rowboat
Quite Possibly The Holy Grail of Investing.
Step 1
: Sell the Put
( This is a Cash Covered Put, I have to have enough Cash to cover if the option is
exercised, this is also
my maximum risk.)
AMRN
@ $15.16
Amarin Corporation plc (AMRN)
Sell to Open AMRN August 2012 $10.00 Put @ Market
Currently .50c bid / .58c time value
5%
return in 27 days
How to do this trade Video:
(Sign up for Auto
–
trading and have this trade done
for you automatically)http://youtu.be/CbO9PNSH0fI
Amarin Corporation plc, a late
–
stage biopharmaceutical company, focuses on developing
the treatment for cardiovascular disease in the field of lipid science.
Its lead product
candidate includes AMR101, a prescription
–
only omega
–
3 fatty acid comprising
icosapent ethyl, or ethyl
–
EPA for the treatment of patients with very high triglyceride
levels and high triglyceride levels or hypertriglyceridemia. The company,
formerly known
as Ethical Holdings plc, was founded in 1989 and is headquartered in Dublin, Ireland.
Amarin Corporation plc
First Floor, Block 3
The Oval
Dublin, 4
Ireland
–
Phone: 353 1 669 9020
Fax: 353 1 669 9028
Website:http://www.amarincorp.com
ELN
@ $13.72
Sell to Open ELN August 2012 $12.00 Put @ Market
Currently $1.10 bid / $1.18 time value
9.16%
return in 25 days
How to do this trade Video:
(Sign up for Auto
–
trading and have this trade done
for you automatically)http://youtu.be/xI75tQCvSkc
Elan Corporation, plc operates as a neuroscience
–
based biotechnology company in the
United States, Ireland, and internationally. It engages in research, dev
elopment, and
commercial activities primarily in the areas of Alzheime risease, Parkinson disease, which completed Phase II clinical
trial. In addition, the company focuses on the discovery and development of antibodies
to neo
–
epitope related targets for the treatment of a range of ind
ications, including
amyloidosis, diabetes, cancer, and macular degeneration; and drugs for oncology
related diseases comprising NEOD001 for the treatment of AL amyloidosis, as well as
focuses on developing ELND005 for bipolar disorder. Further, the company
, through
collaboration agreement with Biogen Idec, Inc., develops and markets Tysabri for the
treatment for Crohn disease. Additionally, Elan Corporation, plc, through a 49.9%
interest in Janssen AI, develops beta amyloid immunotherapies, including
bapi
neuzumab, ACC
–
001, and other compounds to treat Alzheimer The company also has collaboration agreements with Cambridge
–
Elan Centre, Dublin
Neurological Institute, University College Dublin, and Proteostasis. Elan Corporation, plc
was founded i
n 1969 and is headquartered in Dublin, Ireland.
Elan Corporation, plc
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland
Phone: 353 1 709 4000
Fax: 353 1 709 4700
Website:http://www.elan.com
Rememb
er, no more than 5 or 10% of your portfolio should ever go
into any one trade or position.

Step 2:
IF
it got Put to us,
We don’t Panic it is part of the plan.
Now
we “Lock
–
in” a profit.:
Sell
the
Covered Call
(Do not buy this stock just to sell the covered Call)
Nothing got “PUT” to us.
Scroll down to next section for open positions.
Remember, no more than 5 or 10% of your portfolio should ever go
into any one trade or position.
How did we do last Month? / Current/Older
Positions/History
This
includes a running total for each position.
ARNA
@ $9.52
Put expired:
5.55%
Gain
History:
Cost basis
$4.50
per share.
Premiums collected:
.25c
per share
5.55%
Return in 1 months
$10,000 would have generated $555.00
06/18/2012 Sell To Open ARNA Jul12
4.5 Put $0.25
Arena Pharmaceuticals, Inc., a clinical
–
stage biopharmaceutical company, engages in
discovering, developing, and commercializing oral drugs that target G protein
–
coupled
receptors in the therapeutic areas of cardiovascular, central nervous
system,
inflammatory, and metabolic diseases. The company s advanced stage drug candidate
includes the lorcaserin for the treatment of weight management, including weight loss
and maintenance of weight loss. Its product in clinical development comprises AP
D811,
which is under Phase I clinical trial for the treatment of pulmonary arterial hypertension.
The company s preclinical development programs include APD334, an oral treatment for
the treatment of autoimmune diseases, including multiple sclerosis and rh
eumatoid
arthritis; and APD371 for the treatment of pain. The company also researches and
develops GPR119, a pharmaceutical target for discovering orally available small
molecule agonists for the treatment of type 2 diabetes, as well as temanogrel,
nelotan
serin, and earlier
–
stage programs. In addition, the company provides
manufacturing services. Arena Pharmaceuticals, Inc. was founded in 1997 and is based
in San Diego, California
IOC
@ 76.20
InterOil Corporation
got put to us @ $65.00
Called away, lo
cking in a $10 pps (price per share) profit
History:
Cost basis
$65.00
per share.
Premiums collected:
$8.66
per share
13.32%
Premium only
Return in 7 months
Profit per share:
$10.00
Total
$18.66
pps
28.70%
total
Return in 7 months
$10,000 would have
generated
$2870.00
actual trades:
06/18/2012 Sell To Open IOC Jul12 75 Call $2.07
04/23/2012 Sell To Open
IOC Jun12 72.5 Call $1.07
03/20/2012 Sell To Open
IOC Apr12 75 Call $0.40
03/18/2012 Buy To Close
EXPIRED IOC MAR12 75 CALL
02/21/2012 Sell To
Open IOC Mar12 75 Call $1.77
02/17/2012 Buy IOC
–
Option Assignment
$65.00
01/30/2012 Sell To Open IOC Feb12 65 Put $3.35
InterOil Corporation operates as an integrated oil and gas company in
Papua New Guinea. The company engages in the exploration,
a
ppraisal, and development of crude oil and natural gas structures. It
has three onshore exploration licenses covering approximately 3.9
million acres in the Eastern Papuan Basin, northwest of Port Moresby,
Papua New Guinea. The company also engages in the
refining,
producing, retailing, and wholesale of petroleum products, such as jet
fuel, diesel, gasoline, naphtha, and low sulfur waxy residue. In
addition, it markets and distributes avgas, kerosene, and fuel oil, as
well as branded commercial and industri
al lubricants, including engine
and hydraulic oils on a wholesale and retail basis. The company
provides petroleum products to retail service stations operating under
the InterOil brand name and under independent brands; and supplies
petroleum products as
a wholesaler to commercial clients, as well as
operates aviation refueling facilities throughout Papua New Guinea.
Further, the company engages in the construction of liquefaction and
associated facilities, as well as operates two vessels that transport
pe
troleum products within Papua New Guinea and for export in the
South Pacific region. InterOil Corporation was founded in 1990 and is
based in Cairns, Australia.
CLWR
@ $1.02
Hold:
Jan13 $5 Call still cooking
History:
Cost basis
$3.00
per share.
Pre
miums collected:
.85c
per share
28.33%
Return in 11 months
$10,000 would have generated $2833.00
actual trades:
06/18/2012 Sell To Open
CLWR Jan13 5 Call $0.05
09/19/2011 Sell To Open
CLWR Jan12 4 Call $0.30
09/16/2011 Buy To Close
CLWR Sep11 3 Put
09/1
6/2011 Buy CLWR
–
Option Assignment
$3.00
08/23/2011 Sell To Open
CLWR Sep11 3 Put $0.50
Clearwire Corporation, through its subsidiaries, provides fourth generation
wireless broadband services in the United States. The company builds and
operates mobile
broadband networks that offer high
–
speed mobile Internet
and residential Internet access services. It serves retail customers through its
CLEAR brand. The company markets its products and services directly to
consumers, as well as through cellular retailer
s, consumer electronics stores,
satellite television dealers, and computer sales and repair stores; and through
company
–
operated retail outlets. As of December 31, 2011, it had
approximately 1.3 million retail and 9.1 million wholesale subscribers. The
com
pany is headquartered in Bellevue, Washington. Clearwire Corporation is
a subsidiary of Sprint HoldCo LLC.
DMND
@ $17.61
Put to us @ $32.00
Hold
There are no bids on the $33.00 call at this time.
This is a $40.00 stock, I will be patient.
History:
Cost basis
$32.00
per share.
Premiums collected:
1.95
per share
6%
Return in 5 months
$10,000 would have generated
$600.00
actual trades:
03/20/2012 Sell To Open DMND Jun12 33 Call $0.25
03/18/2012 Buy To Close EXPIRED DMND Mar12 32 CALL
02/21/2012
Sell To Open DMND Mar12 32 Call $0.20
02/17/2012 Buy DMND
–
Option Assignment $32.00
02/17/2012 Buy To Close
DMND Feb12 32 Put 02/06/2012 Sell To Open DMND Feb12 32 Put $1.50
Diamond Foods, Inc. engages in processing, marketing, and distributing snack
products. It provides snack products, including roasted, glazed and flavored nuts, trail
mixes, dried fruit, seeds, microwave popcorn products, and potato and tortilla chips
under the Emerald, Pop Secret, and Kettle brands. The company also offers culinar
y,
in
–
shell, and ingredient nuts under the Diamond of California brand name. It markets
its culinary nuts to individuals who prepare meals or baked goods at home; and
ingredient nuts to food processors, restaurants, bakeries, and food service companies
and
their suppliers. The company sells its products directly to national grocery, mass
merchandiser, clubs, convenience stores, and drug store chains in the United States,
the United Kingdom, Germany, the Netherlands, Spain, Canada, South Korea, Turkey,
China
, and Japan. Diamond Foods, Inc. was founded in 1912 and is based in San
Francisco, California.
Diamond Foods, Inc.
600 Montgomery Street
13th Floor
San Francisco, CA 94111
–
2702
Phone: 415
–
445
–
7444
Website:
htt
p
://
www
.
diamondfoods
.
com
FMCN
@ $19.07
Focus Media Holding Ltd
Sell To Open FMCN OCT 2012 $27 Call @ Market
currently @ .45c bid / .53c time
How to do this trade Video:
(Sign up for Auto
–
trading and have this trade done for you au
tomatically)http://youtu.be/VYMa7Rt8GM0
History:
Cost basis $
24.00
per share.
Premiums collected:
$ 1.60
per share
6.6
% Return in 5 months
$10,000 would have generated $1600.00
05/21/2012 Sell To
Open
FMCN Jul12 27 Call$0.40
04/23/2012 Sell To Open
FMCN May12 27 Call $0.45
04/20/2012 Buy FMCN
–
Option Assignment
$24.00
04/20/2012 Buy To Close
FMCN Apr12 24 Put
03/19/2012 Sell To Open
FMCN Apr12 24 Put $1.15
Focus Media Holding Limited, a multi
–
platform digital media company,
operates liquid crystal display (LCD) network using audiovisual digital
displays in China. The company engages in selling out
–
of
–
home advertising
time slots on its network of flat
–
panel digital advertising displays located
in
high traffic areas of commercial, residential, and public buildings, such as malls, hotels, and the lobbies of apartment buildings, as well as in
–
store
network. It provides advertising services on poster frames, on screens in
movie theatres, and on trad
itional outdoor billboards. As of December 31,
2011, the company had a LCD display network of approximately 155,751 flat
–
panel digital displays in approximately 114 cities; in
–
store network of
approximately 50,076 LCD displays in approximately 1,576 hyperm
arkets,
217 supermarkets, and 1,008 convenience stores; poster frame network of
approximately 445,126 non
–
digital frames and LCD 1.0 picture frame
devices, as well as leased screen time in approximately 316 movie theaters,
including 2,190 screens. Focus Me
dia Holding Limited is headquartered in
Central, Hong Kong.
GMCR
@ $17.57
(Put to us @ $40.00)
Hold September $41 call is still cooking
History:
Cost basis $
40.00
per share.
Premiums collected:
$ 2.86
per share
7.15
% Return in 3 months
$10,0
00 would have generated $2860.00
05/21/2012 Sell To Open
GMCR Sep12 41 Call $0.72
04/23/2012 Sell To Open
GMCR May12 40 Put $2.14
Green Mountain Coffee Roasters, Inc. engages in the specialty coffee and
coffee maker business. The company sources, produce
s, and sells
approximately 200 varieties of coffee, cocoa, teas, and other beverages in K
–
Cup portion packs and coffee in traditional packaging, including whole bean
and ground coffee
selections in bags and ground coffee in fractional packs for
use in at
–
h
ome (AH) and away
–
from
–
home (AFH). It sells its products
primarily in North America through supermarkets, club stores, and
convenience stores; in restaurants and hospitality; and to office coffee
distributors, as well as directly to consumers through its W
ebsite. The
company also manufactures gourmet single
–
cup brewing systems and brewing
equipment. In addition, it sells AH single
–
cup brewers; accessories; and
coffee, tea, hot cocoa, and other beverages in K
–
Cup portion packs, as well as
offers other licens
ed roasters to retailers, department stores, and mass
merchandisers. Further, the company sells AFH single
–
cup brewers to
distributors for use in offices. It provides its products under the Van Houtte,
Brûlerie St. Denis, Brûlerie Mont
–
Royal, and Orient Ex
press brands, as well
as licensed Bigelow and Wolfgang Puck brands. The company was founded in
1981 and is based in Waterbury, Vermont.
Green Mountain Coffee Roasters Inc.
33 Coffee Lane
Waterbury, VT 05676
Phone: 802
–
244
–
5621
Fax: 802
–
244
–
5436
Website:http://www.greenmountaincoffee.com

History:
Cost basis
$12.50
per share.
Premiums colle
cted:
$2.25
per share
18%
Return in 8 months
$10,000 would have generated $1800.00
actual trades:
02/21/2012 Sell To Open
TRGT May12 15 Call $0.25
11/28/2011 Sell To Open
TRGT Feb12 15 Call $0.40
11/18/2011 Buy To Close
TRGT Nov11 12.5 Put
11/18/2011 B
uy TRGT
–
Option Assignment $12.50
10/23/2011 Sell to Open TRGT Nov 11 $12.50 PUT $1.60
Targacept, Inc., a biopharmaceutical company, engages in the design,
discovery, and development of novel Neuronal Nicotinic Receptors (NNR)
Therapeutics for the trea
tment of diseases and disorders of the nervous
system. Its lead program, TC
–
5214, a nicotinic channel modulator, is in Phase
3 clinical trials as an adjunct treatment for major depressive disorder (MDD)
and in Phase 2b clinical trial for switch monotherapy
in patients with MDD.
The company s novel small molecule product candidates under Phase 2
clinical development include TC
–
5619 for treating negative symptoms and
cognitive dysfunction in schizophrenia, attention deficit/hyperactivity
disorder, and Alzheim
er s disease; AZD3480 as a treatment for mild to
moderate Alzheimer s disease; AZD1446 as a treatment for Alzheimer s
disease; and TC
–
6987 for the treatment of inflammatory disorders, including
asthma and Type 2 diabetes. It has a collaborative research an
d license
agreement with AstraZeneca AB for the development and commercialization
of AZD3480, TC
–
5214, and TC
–
5619; and a product development and
commercialization agreement with SmithKline Beecham Corporation to
discover, develop, and market product candi
dates that selectively target
specified NNR subtypes in specified therapeutic focus areas. The company
was founded in 1997 and is based in Winston
–
Salem, North Carolina.
Targacept, Inc.
200 East First Street
Suite 300
Winston
–
Salem, NC 27101
–
4165
Phone:
336
–
480
–
2100
Fax: 336
–
480
–
2107
Website:http://www.targacept.com
ZNGA
@ $4.80
Hold
Take no action
There is no good option interest at this time.
History:
Cost basis
$14.00
per share.
Premiums collected:
$2.05
per
share

14.64%
Return in 6 months
$10,000 would have generated
$1464.00
actual trades:
03/19/2012 Sell To Open
ZNGA Apr12 16 Call $0.20
03/18/2012 Buy To Close EXPIRED ZNGA MAR12 15 CALL
02/21/2012 Sell To Open
ZNGA Mar12 15 Call $0.40
02/17/2012 Buy
ZNGA
–
Option Assignment $14.00
02/17/2012 Buy To Close
ZNGA Feb12 14 Put
02/06/2012Sell To Open ZNGA Feb12 14 Put$1.55
Zynga Inc. develops, markets, and operates online social games as
live services on the Internet, social networking sites, and mobile
p
latforms. The company offers its online social games under the
CityVille, Zynga Poker, FarmVille, CastleVille, FrontierVille, Mafia
Wars, Word with Friends, Hidden Chronicles, Zynga Bingo, Scramble
With Friends, Slingo, and Dream Heights names. Its games a
re
available on various platforms, including Facebook and other social
networks, as well as mobile platforms, such as Apple iOS and Google
Android worldwide. The company was formerly known as Zynga Game
Network Inc. and changed its name to Zynga Inc. in No
vember 2010.
Zynga Inc. was founded in 2007 and is headquartered in San
Francisco, California.
Zynga, Inc.
699 Eighth Street
San Francisco, CA 94103
Phone: 855
–
449
–
9642
Fax: 302
–
636
–
5454
Website:http://www.zynga.com
Quote of the Month:
“
Yo
u only have to do a very few things right in your life so long
as you don’t do too many things wrong. “~ Warren Buffet Until Next Time Brad Lee The Options Oracle

Greetings and Welcome aboard to all
new subscribers.
Congrats to all with successful trades.
Company News
Auto Trading is now active!
Don’t want to be bothered
doing the
trades?
Auto
–
trading is for you. Your account will
automatically do whatever I do.
You are still in control, you set the limits
either a dollar amount or a percentage.
Go to:https://theoptionsoracle.com/auto-trading/
“
Ask The Oracle”
webinar Sunday 8 pm
est
to explain this newsletter, or other
questions you might have.
Here is the linkhttp://www.anymeeting.com/MoneyMedic1
Disclosure: These are my actual
trades.
Your su
bscription fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Check with your Licensed
Professional adviserhttps://theoptionsoracle.com/auto-trading/

Disclosure: These are my actual
trades.
Your subscription fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Check with your Licensed Professional adviser
Company News
Auto Trading is now active!
Don’t want to be bothered doing the
trades?
Auto
–
trading is for you. Your account
will automatically do whatever I do.
You are still in control, you set the
limits either a dollar
amount or a
percentage.
Go to the main site, the Auto
–
trade
link is on the sitehttps://theoptionsoracle.com/

We will be doing a webinar
Sunday 8 pm est to explain this
newsletter.
Here is the linkhttp://www.anymeeting.com/MoneyMedic1
Disclosure: These are my actual
trades.
Your subscription fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Check with your Licensed
Professional adviser
Options involve risk and are not suitable
for all investors. Prior to trading op
tions,
you must be approved for options
trading and read the Characteristics
and Risks of Standardized Options.
Copies of this document may also be
obtained from your broker, from any
exchange on which options are traded, by
placing an order online, or by
contacting
the Options Clearing Corporation directly
at 1 N. Wacker Dr., Suite 500, Chicago, IL
60606. (1
–
888
–
678
–
4667).
Brad Lee AKA “The Options Oracle”
and “The Money Medic” is an
individual investor who does not
manage money for any financial
inst
itution.You are purchasing the list
of stocks that he uses to select
options contracts he feels will return
him the highest, safest profits. Brad is
not a broker, or financial adviser. He
is a remarkable investor who has
developed a successful strategy for
himself, and is willing to share some
of his magic with you. We urge you
to paper trade these picks and learn
how to develop a strategy that is
appropriate for you. Thank You.
We make no recommendations on
investment and we do not provide
financial, ta
x or legal advice. Content
and tools are provided for educational
and informational purposes only.
Disclaimer
Trading or investment in stocks, futures &
options, and commodity are subject to potential
market risks. You can use our materials or
recommen
dations for educational purposes,
this is not intended as Trading or Investment
advice. We are not financial advisers. We cannot provide any advice as to whether or not
options or our trading ideas are suitable
investments for your particular financial
sit
uation. We are in the business of publishing
our trade ideas for market analysis only. We
highly recommend that our subscribers review
their trading allocation with a qualified
registered financial adviser/planner.
Legal Disclaimer: we do not exist to re
nder and
do not give legal, tax, economic or investment
advice and disclaims all liability for the actions
or inaction taken or not as a result of
communications from or to its members,
officers, directors, employees and contractors.
Each individual should
consult his/her own
counsel, accountant and other advisors as to
legal, tax, economic, investment and related
matters concerning any type of investments.
This email and any files transmitted with it are
solely intended for the use of the addressee(s)
an
d may contain information that is confidential
and privileged. If you receive this email in error,
please advise us by return email immediately.
Please also disregard the contents of the email,
delete it and destroy any copies immediately.